Oxford BioMedica PLC
LSE:OXB
Oxford BioMedica PLC
LSE:OXB
Price:
318
GBX
-1.4%
Market Cap:
337.1m
GBX
Section:
Wall Street
Price Targets
Wall Street
Price Targets
OXB Price Targets Summary
Oxford BioMedica PLC
Oxford BioMedica PLC
Wall Street analysts forecast OXB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
OXB
is 526.32 GBX
with a low forecast of 383.8 GBX and a high forecast of 840 GBX.
Lowest
Price Target
383.8
GBX
21% Upside
Average
Price Target
526.32
GBX
66% Upside
Highest
Price Target
840
GBX
164% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OXB's stock price target?
Price Target
526.32
GBX
526.32
GBX
According to Wall Street analysts, the average 1-year price target for
OXB
is 526.32 GBX
with a low forecast of 383.8 GBX and a high forecast of 840 GBX.
What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
25%
25%
For the last 13 years the
compound annual growth rate for
Oxford BioMedica PLC's revenue is
24%.
The projected
CAGR
for the next 3 years is
25%.
You don't have any saved screeners yet
